Table 4.

Odds ratios and 95% confidential intervals of presence of DPN according to metabolic and anthropometric components

Variable	Unadjusted model	P	Adjusted model	P
Glucose (mg/dL)	1.009 (0.997–1.021)	0.147	1.009 (0.996–1.023)	0.160
HbA1c (%)	1.336 (0.940–1.899)	0.107	1.394 (0.932–2.084)	0.106
Triglyceride (mg/dL)	1.001 (0.999–1.004)	0.360	1.002 (0.999–1.005)	0.104
HDL cholesterol (mg/dL)	0.983 (0.947–1.019)	0.347	0.978 (0.938–1.019)	0.281
SBP (mmHg)	1.040 (0.997–1.085)	0.069	1.056 (1.004–1.111)	0.034
DBP (mmHg)	1.032 (0.973–1.095)	0.300	1.067 (0.985–1.155)	0.111
HOMA-IR	1.561 (1.079–2.258)	0.018	1.673 (1.091–2.565)	0.018
WC (cm)	1.086 (1.018–1.158)	0.013	1.151 (1.055–1.256)	0.002
BMI (kg/m2)	1.210 (1.033–1.417)	0.018	1.266 (1.045–1.534)	0.016
Fat mass (kg)	1.095 (1.012–1.186)	0.025	1.131 (1.021–1.252)	0.018
Fat percent (%)	1.091 (1.018–1.170)	0.014	1.147 (1.030–1.277)	0.013
Lean body mass (kg)	0.984 (0.934–1.036)	0.533	0.988 (0.896–1.090)	0.811
Visceral fat area (cm2)	1.018 (1.003–1.035)	0.022	1.026 (1.005–1.048)	0.015

Values are presented as odds ratio (95% confidential interval). Adjusted model was adjusted for age, sex, diabetes duration, and smoking status.

DPN, diabetic peripheral neuropathy; HbA1c, glycosylated hemoglobin; HDL, high-density lipoprotein; SBP, systolic blood pressure; DBP, diastolic blood pressure; HOMA-IR, homeostatic model assessment for insulin resistance; WC, waist circumference; BMI, body mass index.